SME IPOs Shine Bright: 29 Stocks Deliver Multibagger Returns in Challenging Market

1 min read     Updated on 28 Dec 2025, 10:40 AM
scanx
Reviewed by
Shraddha JScanX News Team
Overview

In a challenging market year, 29 SME stocks have delivered returns exceeding 100% from their IPO prices. Anondita Medicare leads with over 500% gains. The SME sector's resilience offers diversification opportunities and growth potential for investors. However, caution is advised due to higher risks associated with SME stocks.

28444255

*this image is generated using AI for illustrative purposes only.

In a year marked by market turbulence, the small and medium enterprise (SME) segment has emerged as a beacon of hope for investors. Despite challenging market conditions, 29 SME stocks have defied the odds, delivering stellar returns of over 100% from their initial public offering (IPO) prices.

SME Sector Resilience

The SME sector has demonstrated remarkable resilience in the face of sector-wide struggles. While larger companies have grappled with various economic headwinds, these smaller enterprises have managed to carve out significant growth, rewarding early investors handsomely.

Top Performers

Leading the pack of outperformers is Anondita Medicare, which has registered an impressive gain of over 500% from its IPO price. This extraordinary performance underscores the potential of well-positioned SMEs in niche markets.

Market Implications

The success of these SME stocks amid a challenging market environment highlights several key points:

  1. Diversification Opportunities: The SME segment offers investors a chance to diversify their portfolios beyond large-cap stocks.
  2. Growth Potential: Smaller companies often have more room for rapid growth compared to their larger counterparts.
  3. Market Inefficiencies: The SME market may present opportunities for astute investors to identify undervalued companies.

Investor Caution

While the returns are impressive, it's crucial for investors to approach SME stocks with due diligence. These stocks often come with higher risks, including liquidity concerns and potential volatility.

Looking Ahead

The strong performance of select SME stocks may attract more investor attention to this segment. However, it remains to be seen whether this trend will continue in the face of ongoing market challenges.

Investors are advised to conduct thorough research and consider their risk tolerance before making investment decisions, especially in the dynamic SME sector.

like19
dislike

29 SME IPOs Deliver Multibagger Returns Despite Challenging Market Conditions in 2025

3 min read     Updated on 28 Dec 2025, 10:38 AM
scanx
Reviewed by
Riya DScanX News Team
Overview

Despite challenging conditions in 2025, 29 SME stocks delivered multibagger returns exceeding 100% from IPO prices, led by Anondita Medicare's 500%+ gains. While over 250 SME IPOs raised nearly ₹11,000 crore, average listing gains fell to 12.60%—the weakest since 2020. Successful companies operated in niche sectors like healthcare and manufacturing, demonstrating that quality fundamentals continued to drive performance even amid broader market struggles.

28444084

*this image is generated using AI for illustrative purposes only.

India's SME IPO market experienced a sharp reality check in 2025, with the segment facing significant headwinds despite record fundraising levels. However, a select group of 29 SME stocks managed to deliver exceptional multibagger returns, proving that quality fundamentals can drive performance even during challenging market conditions.

Market Performance Overview

According to data from Trendlyne, approximately 29 SME stocks delivered gains exceeding 100% from their IPO prices, standing out in a year when the broader SME universe struggled significantly. This performance becomes more remarkable considering the overall market sentiment and reduced enthusiasm for SME IPOs throughout 2025.

Market Metric 2025 Performance Context
Total SME IPOs Over 250 Highest count
Total Fundraising Nearly ₹11,000 crore Highest annual amount
Average Listing Gains 12.60% Weakest since 2020
Flat/Negative Debut Returns ~120 IPOs vs. 33 in 2024
Trading Below Issue Price ~130 IPOs Significant underperformance

This marked a dramatic shift from the previous period between 2022 and 2024, when average SME IPO listing gains surged from roughly 33% to almost 60%, fueled by abundant liquidity, aggressive retail participation, and minimal price discipline.

Top Performing Stocks

Among the standout performers, several companies delivered exceptional returns ranging from 250% to over 500% from their IPO prices. Anondita Medicare led the pack with particularly impressive performance, listing at ₹145—a steep 90% premium over the issue price—and subsequently climbing to over ₹900, translating into gains exceeding 500%.

Top Performers Return Range Sector Focus
Anondita Medicare Over 500% Healthcare
Tankup Engineers Over 300% Engineering Solutions
Fabtech Technologies Cleanrooms Over 300% Cleanroom Infrastructure
Cryogenic OGS 250%+ Industrial Services
Monolithisch India 250%+ Manufacturing

Financial Performance Highlights

Anondita Medicare's strong post-listing performance was supported by robust financial growth over the past two years. The company demonstrated exceptional operational improvements across key metrics.

Financial Metric FY25 FY24 Growth
Revenue ₹77.13 crore ₹46.56 crore 66%
Profit After Tax ₹16.42 crore ₹3.84 crore 327%

Similarly, other multibagger performers like Tankup Engineers and Fabtech Technologies Cleanrooms delivered gains exceeding 300%, defying the broader SME market slowdown through strong fundamentals and sector positioning.

Market Differentiation Factors

Analysts noted that successful companies distinguished themselves through several key characteristics rather than market hype. Many multibagger performers operated in niche sectors including manufacturing, industrial services, healthcare, engineering solutions, and cleanroom infrastructure—segments where order books, client relationships, and execution capabilities proved more important than sentiment-driven trading.

Additionally, several successful IPOs demonstrated strong subscription levels, often running into hundreds or thousands of times oversubscription, particularly in HNI and retail categories. While high subscription alone did not guarantee success in 2025, it helped signal areas of strong investor conviction.

Market Evolution and Outlook

The SME platform was originally designed to address structural gaps in Indian capital markets, providing funding access to small and medium enterprises that historically relied on bank loans or private funding. However, speculative excess gradually emerged, leading to regulatory intervention by SEBI in late 2024 and 2025.

"Investors need to select companies meticulously, with thorough fundamental analysis. Businesses with sound models, strong profitability, favorable industry prospects and reasonable valuations can still deliver long-term multibagger returns," said Sunil Nyati, MD at Swastika Investmart.

The fact that only a subset of stocks delivered multibagger returns in 2025 may signal market maturation, with improved quality standards and investor scrutiny becoming more prominent factors in performance outcomes.

like16
dislike
More News on IPO Market
Explore Other Articles